Ecological evidence
Badger culling drives animals further afield increasing risk of TB spread
New research reveals survivors of culls cover greater areas potentially increasing the risk of TB transmission to cattle.
Badger culling drives animals further afield increasing risk of TB spread
New research reveals survivors of culls cover greater areas potentially increasing the risk of TB transmission to cattle.
TB meningitis kills and damages nerve cells in brain through ‘overstimulation’
Study reveals how tuberculous meningitis (TBM) damages the nervous system along similar lines as chronic brain conditions such as Alzheimer’s.
Emerging tech solutions to global AMR threat take centre stage at White City
Summit explores the role of emerging tech developments in optimising the use of antimicrobials, combatting AMR and supporting infection management.
Symposium sets new direction for infectious diseases research at Imperial
Infectious diseases experts shared their latest work at an annual research symposium hosted at Imperial’s Hammersmith Campus last month.
Feature
How can moths help us to develop better tuberculosis treatments?
PhD student Masanori Asai discusses why he's using moth larvae to study tuberculosis (TB) infection.
Feature
End TB: Four ways Imperial is tackling the world's deadliest infectious killer
To mark World Tuberculosis Day, we look at the different ways our researchers are addressing a disease that continues to be a global issue.
2
Imperial launches its first public health online degree
The Global Master of Public Health, developed alongside Coursera, is Imperial's first fully-online degree in the health field.
New blood tests for TB could accelerate diagnosis and save the NHS money
Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.
Anti-inflammatory drug reduces key complication risk in HIV-positive TB patients
Trial finds that prednisone can reduce the risk of TB-IRIS – a serious complication seen in HIV-positive tuberculosis (TB) patients.
Potential tuberculosis vaccine shows early promise in clinical trial
Ongoing clinical trial yields positive preliminary results for candidate tuberculosis (TB) vaccine M72/AS01E1.